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The motor examination section of the unified Parkinson’s disease rating scale (UPDRS) is widely used in research but few studies
have examined whether subscales exist that tap relatively distinct motor abnormalities. We analyzed data from 193 persons enrolled
in a population-based study in Central California. Patients were examined after overnight PD medication washout (“OFF” state)
and approximately one hour after taking medication (“ON” state). We performed confirmatory factor analysis of the UPDRS for
OFF and ON state examinations; correlations, reliability, and relative validity of resulting subscales were evaluated. A model with
five factors (gait/posture, tremor, rigidity, bradykinesia aﬀecting the left extremities, bradykinesia aﬀecting the right extremities)
fit the data well, with similar results for OFF and ON states. Internal consistency reliability coeﬃcients were 0.90 or higher for
all subscales. The gait/posture subscale most strongly discriminated across levels of patient reported PD symptom severity and
of how PD aﬀects them on a daily basis. Compared to the right sided bradykinesia subscale, the left sided bradykinesia subscale
had higher discrimination across levels of self-reported PD symptom severity and functional impairment. This supports motor
UPDRS containing multiple subscales that can be analyzed separately and provide information distinct from the total score that
may be useful in clinical studies.
1. Introduction
The motor examination section (Part III) of the unified Par-
kinson’s disease rating scale (UPDRS) is themost widely used
measure to assess motor symptoms and signs in Parkinson’s
disease (PD) [1]. The motor section is the only component
of the UPDRS where items are scored by the physician
rather than by patient self-report. An overall measure of
motor abnormalities may not discern beneficial eﬀects of
treatments that might target certain motor components, or
enable identification of subsets of patients with diﬀerent
motor examination profiles and prognoses.
A previous study reported an exploratory factor analysis
of the factor structure of the motor UPDRS in a sample
of patients with idiopathic PD in the ON state (taking
their usual medications) [2]. Six factors were identified;
axial functioning and gait, rest tremor, rigidity, bradykinesia
aﬀecting the left extremities, bradykinesia aﬀecting the
right extremities, and postural tremor. However, this prior
study employed principal component analysis, and assumed
continuous data. The motor UPDRS consists of five-category
ordinal items scored 0–4. A followup study performed a
confirmatory factor analysis in the OFF state (as part of
regular care visits throughout the day) in an independent
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sample and found similar item loadings for the 6 factors
obtained from initial exploratory factor analysis in the ON
state [3].
All previous evaluations of the factor structure of the
Motor UPDRS have been in separate samples of PD patients
in either the ON or OFF states [2, 3] or in a sample con-
taining patients with mixed medication states [4]; therefore,
diﬀerences in factor structure between medication states
were not assessed.
The present study re-examines the previously defined
factor structure of the items of the motor UPDRS using
categorical confirmatory factor analysis in both ON and OFF
states in the same group of patients, accounting, for the
ordinal distributions of the motor UPDRS items.
2. Methods
2.1. Sample. The Parkinson’s, Environment, and Gene
(PEG) study enrolled 371 subjects between 1998 and 2006
who had been diagnosed with PD within the prior three
years [5, 6]. Between June 2007 and June 2009, 254 of the
original cohort were eligible, consented, and participated
in a followup study assessing the progression of disease.
Patients were examined by a movement disorder specialist
and completed in-person and telephone interviews [7]. The
UPDRS was administered in both the OFF medication state
(patients withholding all PD medications for at least 12
hours prior to assessment) and the ON medication state
(one hour after taking their usual morning PD medica-
tions that same day). Subjects without both an OFF and
ON exam were excluded from this analysis. Reasons for
not completing both exams included, not being able to
withhold morning medications (n = 16; only ON exam
performed), no PD medications prescribed (n = 12; only
OFF exam performed), did not bring medications to the
exam (N = 3; only OFF exam performed), or no reason
recorded (n = 6). An additional 24 participants could not
undergo an in-person exam, yielding an analytic sample of
193.
The UCLA IRB (#G06-07-055) approved all study proce-
dures, and all subjects provided informed consent.
2.2. Measures. The motor UPDRS exam is the summation of
27 physician-rated items each scored on a 0 (no impairment)
to 4 (severe impairment) categorical scale. Items are included
assess motor abnormalities such as rest tremor, action
tremor, rigidity, bradykinesia, gait and posture, and facial
masking. The total motor UPDRS exam score ranges from
0 to 108.
Self-ratings of the eﬀects of PD on day-to-day activi-
ties and PD symptom severity were assessed during tele-
phone interviews administered by trained research assistants.
Responses from 23 patients were excluded because the self-
reported ratings were administered more than 30 days after
the UPDRS exams. Participants were asked to indicate one
choice that “best describes how your Parkinson’s disease has
aﬀected your day-to-day activities in the last month:” (1)
no diﬃculties, (2) mild diﬃculties, (3) moderate diﬃculties,
(4) high levels of diﬃculties, or (5) extreme diﬃculties.
Each response option was followed by a detailed example.
This single item was developed specifically for PD based
on interviews with PD specialist clinicians, patients, and
caregivers, as well as on a literature review. Construct validity
of the itemwas supported by its associations with depression,
cognition, and PD severity in a community based PD sample
[8]. Participants were also asked to rate the severity of their
PD symptoms in the past 6 months as (1) no symptoms,
(2) mild symptoms, (3) moderate symptoms, and (4) severe
symptoms.
2.3. Data Analyses. Categorical confirmatory factor analysis
was performed on the 27 items of the motor UPDRS to eval-
uate factors identified previously in PD patients in both ON
and OFF states [2, 3]. Models were estimated using weighted
least square parameter estimates using a diagonal weight
matrix with robust standard errors using MPLUS version 6
software (Los Angeles, CA) [9]. Analyses were performed
using OFF state total motor UPDRS scores to capture
untreated motor symptoms. Model fit was evaluated using
three goodness-of-fit indices including the comparative fit
index (CFI), the Tucker-Lewis Index (TLI), and the root
mean squared error of approximation (RMSEA). In general,
a CFI above 0.95 [10], a TLI above 0.95, and a RMSEA
value lower than 0.06 signify good model fit [11]. Finding
the optimum model is an exploratory process, but is a
common procedure when the original model does not have
the best possible fit [12]. In the initial model parameter
from the Stebbins model were fixed and all correlations were
set free. Then, using modification indices and conceptual
acceptability a series of models were fit fixing correlations
between items and correlations between subscales. Once
a final model was determined, the same model was per-
formed for the ON state UPDRS items, and results were
compared.
Scales were calculated by taking the mean of the final
set of items from each factor in the confirmatory factor
analysis, transformed linearly to have a 0 to 100 possible
range, where 0 is the best state. For each scale, themean score,
standard deviation, and observed minimum and maximum
were calculated. Internal consistency reliability was estimated
using Cronbach’s alpha [13]. Subscales with a Cronbach’s
alpha of 0.70 or greater are considered adequate for group
comparisons while scales with reliabilities of 0.90 or above
are suﬃcient for individual applications [14].
Relationships between the total motor UPRDS score and
newly developed scale scores in the ON and OFF states were
assessed using product-moment correlations. We classified
correlations greater than 0.50 as large, 0.30–0.50 as moderate
and 0.10–0.29 as small [15]. To eliminate overlap between
the total motor UPDRS scores and the scales, items for a
particular scale were excluded from the total motor UPDRS
score prior to computing the product-moment correlation.
Relative validity evaluates the extent to which two or
more scores are associated with an external criterion as
hypothesized [16]. We evaluated the relative validity of the
total motor UPDRS score and the scales relative to two
external criteria; the single item self-rating of the impact of
PD on day-to-day activities, and the single item self-rating of
Parkinson’s Disease 3
Table 1: Clinical and sociodemographic characteristics (n = 193).
N (%) unless specified
Age in years: mean (SD) 72.4 (9.2)
Female 79 (41)
Ethnicity
White or European American 152 (79)
Latino or Hispanic 30 (16)
Other∗ 11 (6)
Highest level of education
Did not finish grade school (grades 1–8) 10 (5)
Finished grade school but no high school diploma 17 (9)
High school diploma 73 (38)
Technical or trade school diploma 21 (11)
College diploma 34 (18)
Graduate school diploma 28 (15)
Cannot remember/Refused/Do not know/Other 10 (5)
Marital status (n = 190)
Never married 6 (3)
Married 145 (76)
Divorced/Separated 15 (8)
Widowed 24 (13)
Work status
Employed 35 (18)
Retired 143 (74)
Other: unemployed (5), disabled (8), emeritus (1), housewife (1), temp work (1) 15 (8)
Mean duration of PD diagnosis, years (SD) 5.2 (2.3)
Modified Hoehn and Yahr Stage (OFF state)
Stage 1: Unilateral disease 10 (5)
Stage 1.5: Unilateral plus axial involvement 9 (5)
Stage 2: Bilateral disease, without impairment of balance 64 (34)
Stage 2.5: Mild bilateral disease with recovery on pull test 54 (28)
Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent 34 (18)
Stage 4: Severe disability; still able to walk or stand unassisted 12 (6)
Stage 5: Wheelchair bound or bedridden unless aided 7 (4)
Medication status∗∗
Levodopa only 67 (35)
Levodopa and any other medication 108 (56)
Dopamine agonists without Levodopa 17 (9)
How Parkinson’s disease aﬀects you on a day-to-day basis?∗∗∗
No diﬃculties 27 (16)
Mild diﬃculties 94 (55)
Moderate diﬃculties 39 (23)
High levels or extreme diﬃculties 10 (6)
During the past 6 months, how would you rate the severity of your Parkinson’s disease symptoms? ∗∗∗
No symptoms 4 (2)
Mild symptoms 79 (47)
Moderate symptoms 79 (47)
Severe symptoms 8 (5)
∗
Other race includes African America, Native American, or Asian or Pacific Islander.
∗∗One subject excluded because they were on MAO-B inhibitors alone.
∗∗∗Subjects with self-rated reports within 30 days of motor UPDRS exam (n = 170).
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Figure 1: Confirmatory factor analysis results OFF medication. Single headed arrows indicate factor loadings, which double headed arrows
indicate residual correlations.
severity of PD symptoms. Mean scores on the motor UPDRS
total and subscales were compared across response levels of
each item. One-way ANOVA F-statistics were computed for
each scale, and the significance of diﬀerences between pairs of
groups was estimated using Duncan’s multiple range test. We
report relative validity as F-statistics; the ratio of a scale’s F-
statistic to that of a reference scale (the scale with the smallest
F-statistic). Therefore, the scale with the highest F-ratio is the
most sensitive to diﬀerences across categories of the external
criteria variable [17].
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Table 2: Factor loadings for confirmatory factor analysis oﬀ and on Parkinson disease medications.
OFF medication ON medication
Factor loadings Factor loadings
Tests of model fit
CFI 0.962 0.963
TLI 0.955 0.956
RMSEA 0.059 0.060
Factor 1: Gait/Posture
Speech 0.681 0.677
Facial expression 0.640 0.635
Arising from chair 0.752 0.781
Posture 0.800 0.788
Gait 0.744 0.761
Postural stability 0.572 0.591
Body bradykinesia and hypokinesia 0.874 0.861
Factor 2: Tremor
Tremor at rest—face, lips, chin 0.621 0.604
Tremor at rest—right hand 0.220 0.236
Tremor at rest—left hand 0.772 0.752
Action/Postural tremor—right hand 0.480 0.499
Action/Postural tremor—left hand 0.818 0.833
Factor 3: Rigidity
Rigidity—neck 0.471 0.461
Rigidity—right lower limb 0.914 0.917
Rigidity—left lower limb 0.892 0.882
Factor 4: Right
Rigidity—right upper limb 0.682 0.687
Finger taps—right hand 0.594 0.601
Hand movements—right hand 0.712 0.709
Rapid movements—right hand 0.711 0.709
Leg agility—right leg 0.768 0.770
Factor 5: Left
Rigidity—left upper limb 0.788 0.781
Finger taps—left hand 0.778 0.786
Hand movements—left hand 0.806 0.802
Rapid movements—left hand 0.814 0.798
Leg agility—left leg 0.797 0.726
CFI: Comparative fit index; TLI: Tucker-Lewis Index; RMSEA: Root mean square error of approximation.
3. Results
Participants had an average age of 73 years, 41% were female
and 79% were non-Hispanic white. The average duration
of PD diagnosis was 5 years, and 72% were Hoehn & Yahr
stage (in OFF state) 2.5 or lower. Nearly 35% of participants
were taking levodopa only, 56% were taking levodopa
with another medication (i.e., amantadine, trihexyphenidyl
and/or entacapone), and only 9% were taking a dopamine
agonist without levodopa (Table 1).
3.1. Confirmatory Factor Analysis. We started with the 6-
factor model previously reported [2, 3], but after fitting eight
sequential models, we found that a five factor model fit
the data better: CFI = 0.962, TLI = 0.955, RMSEA = 0.059
(Figure 1). Factor loadings ranged from 0.22 to 0.91 (median
= 0.75; standard deviation = 0.15). This model included
19 unique correlations between pairs of items, denoted as
residual correlations in Figure 1.
Items measuring speech, facial expression, arising from a
chair, posture, gait, postural instability, and body bradyki-
nesia comprised Factor 1. Factor 2 included the three rest
tremor measures and both postural tremor measures. Foot
tremor scores did not meet criteria to be included directly
into Factor 2, but correlated best with ipsilateral hand tremor
measures. Factor 3 is made up of rigidity measures (neck,
right, and left lower limbs). Factors 4 and 5 include measures
of right and left bradykinesia, respectively.
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Table 3: Descriptive statistics for UPDRS motor score and subscales (n = 193)∗.
Mean (SD)
Cronbach’s
alpha
Minimum
observed
value
Maximum
observed
value
Percent scoring possible
minimum
(best)/maximum (worst)∗
Total Motor UPDRS Motor
(27 items; range 0 to 108)
OFF 25.0 (11.7) 0.89 5 66 0.0/0.0
ON 17.2 (10.8) 0.89 1 64 0.0/0.0
Gait/Posture (7 items; range 0 to 100)
OFF 30.6 (17.2) 0.91 0 82 2.1/0.0
ON 23.5 (17.3) 0.91 0 82 3.6/0.0
Tremor (5 items; range 0 to 100)
OFF 14.9 (12.6) 0.92 0 60 14.5/0.0
ON 8.8 (9.9) 0.92 0 55 33.7/0.0
Rigidity (3 items; range 0 to 100)
OFF 14.8 (14.8) 0.91 0 58 27.9/0.0
ON 7.6 (11.5) 0.91 0 58 53.4/0.0
Right (5 items; range 0 to 100)
OFF 27.7 (15.6) 0.91 0 80 3.6/0.0
ON 18.6 (14.4) 0.91 0 60 14.5/0.0
Left (5 items; range 0 to 100)
OFF 29.0 (19.4) 0.91 0 80 9.4/0.0
ON 20.6 (16.9) 0.90 0 75 17.1/0.0
∗
All scales and subscales are scored so that higher values indicate more severely aﬀected. Possible range for total motor UPDRS score is 0 (best) to 108 (worst).
Possible range for subscales is 0 (best) to100 (worst).
When this same 5-factor model was estimated for
UPDRS items in the ON state, similar fit (CFI = 0.963, TLI =
0.956, RMSEA = 0.060) and factor loadings were obtained to
that found for the OFF state (Table 2).
Internal consistency reliability was 0.90 or higher for the
five subscales formed from the items loading on the five
factors (Table 3). There were floor eﬀects for the rigidity
subscale in the ON state (53% of the sample scored the
possible minimum = least rigidity) and the tremor subscale
in the ON state (38% of the sample scored the possible
minimum). These floor eﬀects were greatly reduced in the
same scales in the OFF state (28% of the sample scored the
possible minimum on the rigidity subscale, and 14% scored
the possible minimum on the tremor subscale).
3.2. Correlations of Total Motor UPDRS Score with the Five
Scale Scores. Table 4 shows the correlations of the total motor
UPDRS score with the five subscales for both OFF and ON
states, corrected for item overlap. The gait/posture, rigidity,
and right and left bradykinesia subscales had moderate to
high correlations with the total motor UPRDS score both in
the OFF state (r = 0.45–0.65) and ON state (r = 0.43–0.70).
The tremor subscale has the lowest association with the total
UPDRS (r = 0.19 OFF state, r = 0.27 ON state). There
were small correlations between the tremor subscale and the
other subscales, both OFF medication (r ≤ 0.17) and ON
medication (r ≤ 0.23).
3.3. Relative Validity. How PD aﬀects you on a day-to-day
basis: Sixteen percent of participants reported no diﬃculties,
56% reported mild diﬃculties, 22% reported moderate diﬃ-
culties, and 6% reported high levels or extreme diﬃculties.
Due to few responses for high levels of diﬃculties and
extreme levels of diﬃculties, these two levels were com-
bined. The level of discrimination across the four categories
was high for the total motor UPDRS (relative validity =
35.43 OFF state and 37.43 ON state). Of the 5 subscales,
gait/posture subscale had highest relative validity (relative
validity = 37.95 ON state and 37.38 OFF state). The tremor
subscale had the lowest relative validity of the five subscales
(relative validity = 2.26 OFF state and 1.00 ON state). Right
and left subscales had similar discrimination in theOFF state,
while the left subscale had higher relative validity compared
to the right subscale in the ON state. (Table 5(a)).
PD symptoms severity rating: four patients reported no
PD symptoms, 90 reported mild symptoms, 88 reported
moderate symptoms, and 10 reported severe symptoms. The
total motor UPDRS had high discrimination across the four
PD symptom severity categories (relative validity = 5.56
OFF medication and 6.47 ON medication).The gait/posture
subscale OFF medication, and left bradykinesia subscale
ON medication had higher relative validity than the other
subscales (relative validity = 5.55 and 5.82, resp.). The tremor
subscale had the lowest relative validity (relative validity =
1.00OFFmedication and 1.79ONmedication). (Table 5(b)).
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Table 5: (a) Relative validity of total motor UPDRS and subscales by how PD aﬀects on day-to-day basis ratings∗, (b) Relative validity of
total motor UPDRS and subscales by PD symptoms severity (n = 170).
(a)
How Parkinson’s disease aﬀects you on a day-to-day basis? (n = 170)
No diﬃculties
(n = 27)
Mild diﬃculties
(n = 94)
Moderate
diﬃculties (n = 39)
High levels or extreme
diﬃculties (n = 10)
F ratio∗
Relative
validity
OFF medications
Total motor
UPDRS
18.2a 23.3a,b 28.3b 42.4c 14.88 35.43
Gait/Posture 21.4a 27.4a 39.5b 53.9c 15.94 37.95
Tremor 13.3a 14.7a 13.6a 20.5a 0.95 2.26
Rigidity 7.1a 14.2a 15.0a 30.0a 6.58 15.67
Right 22.8a 26.3a 29.1a 46.5b 6.44 15.33
Left 19.3a 26.8a,b 33.3b 49.0c 7.48 17.81
ON medications
Total motor
UPDRS
11.6a 15.5a,b 20.5b 33.7c 15.73 37.43
Gait/Posture 15.2a 20.1a 33.1b 44.6c 15.70 37.38
Tremor 7.6a 8.8a 7.4a 10.5a 0.42∗∗ 1.00
Rigidity 2.5a 7.0a 7.7a 22.5b 8.49 20.21
Right 14.4a 17.2a 20.1a 36.0b 6.74 16.05
Left 12.6a 18.7a,b 23.1b 44.5c 10.76 25.62
All scales/subscales are scored so that higher values indicate more severely aﬀected. Possible range for total motor UPDRS score is 0 (best) to 108
(worst). Possible range for subscales is 0 (best) to 100 (worst).
a, b, and c means within a row with diﬀerent letters diﬀer significantly (P ≤ 0.05; Duncan multiple range).
∗One way between group ANOVAs of total motor UPDRS or subscale and day-to-day eﬀects of PD.
∗∗Reference subscale = ON medication − Tremor.
(b)
During the last 6 months, how would you rate the severity of your Parkinson’s disease symptoms?
No symptoms
(n = 4)
Mild symptoms
(n = 79)
Moderate
symptoms (n = 79)
Severe symptoms
(n = 8)
F ratio∗
Relative
validity
OFF medication:
Total motor
UPDRS
14.0a 21.3a,b 27.6b,c 36.1c 8.28 5.56
Gait/Posture 16.1a 25.3a,b 35.6b,c 43.8c 7.70 5.17
Tremor 8.8a 12.9a 16.1a 18.8a 1.49∗∗ 1.00
Rigidity 12.5a 11.8a 15.9a 20.8a 1.64 1.10
Right 22.5a 25.3a,b 29.1a,b 38.1b 2.11 1.42
Left 8.8a 23.9a,b 32.0b,c 46.9c 6.57 4.41
ON medication:
Total motor
UPDRS
8.8a 14.1a,b 19.0b 31.1c 9.64 6.47
Gait/Posture 11.6a 19.2a,b 27.3b,c 39.7c 6.55 4.40
Tremor 1.3a 7.2a,b 9.4a,b 14.4b 2.66 1.79
Rigidity 6.3a 4.5a 9.7a 12.5a 3.39 2.28
Right 13.8a 16.7a 19.2a,b 31.9b 3.03 2.03
Left 8.8a 16.4a 22.2a 44.4b 8.67 5.82
All scales/subscales are scored so that higher values indicate more severely aﬀected. Possible range for total motor UPDRS score is 0 (best) to 108
(worst). Possible range for subscales is 0 (best) to 100 (worst).
a, b, and c means within a row with diﬀerent letters diﬀer significantly (P ≤ 0.05; Duncan multiple range).
∗One way between group ANOVAs of total motor UPDRS or subscale and rating of severity of PD symptoms.
∗∗Reference subscale = OFF medications − Tremor.
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4. Discussion
This study evaluated the six-factor solution of the motor
section of the UPDRS identified in prior studies. We found
that all tremor items fit on the same factor rather than
being divided into rest tremor and postural tremor. The
other four factors we identified were consistent with prior
work [2, 3]. Similar to Stebbins et al., a 7-item gait/posture
factor was identified that includes speech, facial expression,
arising from a chair, posture, gait, postural instability, and
body bradykinesia. However, all tremor items in our model
loaded together on one factor, as opposed to the analysis by
Stebbins et al., where the two postural tremor items fell into
a separate factor from the rest tremor factor. The foot tremor
items that were included in Stebbins’ rest tremor factor did
not meet load on the gait/posture factor in our analysis,
but are correlated with the hand tremor items. Analogous
to Stebbins et al., we found the rigidity measures formed
a factor, as well as two factors measuring right and left
bradykinesia. The right and left upper limb rigidity items
loaded on the right and left bradykinesia factors, rather than
on the rigidity factors that was reported in the Stebbins
model.
The diﬀerences we found could be due to variation
caused in a new sample. It is also possible that diﬀerences in
the assumptions of the analyses contributed to the diﬀer-
ences. That is, we use an estimation that accounted for the
ordinal nature of the motor UPDRS items.
The low correlations of the tremor scale with the other
subscales in both ON and OFF medication states suggests
that the tremor subscale is measuring distinct aspects of PD
impairment. Stebbins et al. found similar low correlations
when the same items were split into the rest tremor and
postural tremor factors in both medication states. The low
correlations of tremor with other symptoms may reflect the
relative refractory improvement of tremor to medications
compared to rigidity and bradykinesia. In addition, tremor
predominant PD cases present in the population would
contribute to this dissociation as well and be an indicator
of the lack of relationship between higher level of tremor
and greater PD impairment. The low correlation of the
tremor subscale with other symptom scales also supports
previous suggestions that tremor in PD may have diﬀerent
pathophysiological mechanisms as compared to the other
motor symptoms of PD [18–20].
Analyses revealed that the gait and balance subscales
had a larger impact on subjective reporting of PD symptom
severity and functional impairment due to PD. Conversely,
tremor had little contribution to these ratings. This suggests
that the features of PD that have the greatest functional
impact are those that impair independent mobility. Mobility
issues become quite problematic as the disease progresses,
given the need for acceleration of the use of assist devices
(from cane to walker to wheelchair).
Similar to Stebbins et al., side-sensitive bradykinesia
was represented in the right and left factors. The right
subscales had lower relative validity than the left subscales
for both self-reported PD symptom severity and functional
impairment. This could be due to greater diﬃculties with
involvement of the dominant (right) versus nondominant
side of the body, or to increased verbal problems reportedly
associated with greater right-side involvement [21]. Also,
depression is common in PD, and there is some literature
to suggest an association between depression and laterality
of motor symptoms in PD [22, 23]. Further research with
these UPDRS subscales, subjective self-report PD severity,
and impairment and their association with hand dominance,
cognition, and mood is indicated.
The factor structures were very similar for the ON state
and OFF state. Because the OFF state captures untreated
motor symptoms and covers a wider range of disease severity,
the resulting scales may be generalizable to groups with
diﬀerent of ranges disease severity. In addition, all subscales
had very high internal consistency reliability, exceeding or
equaling 0.90.
Regarding potential limitations, a low subject-to-variable
ratio can lead to higher standard errors. However, the param-
eter estimates and correlations used in our models were all
significant, and our subject-to-variable ratio of 7 : 1 exceeded
a recommended minimum of 5 : 1 [24, 25].
These findings support prior work that identified an
underlying structure of motor UPDRS examination and sup-
port the use of the resulting subscales in clinical and research
settings to assess separate aspects of motor abnormalities of
PD to enable determination of diﬀerential treatment eﬀects
or prognosis.
While the newer version of the scale, the MDS-UPDRS,
is gaining wider use, there is a large overlap of the items
from the original UPDRS to the MD-UPDRS, and mapping
of ratings between the two scales exist [26]. Evaluations of
the two scales show extremely high correlations between the
motor sections of the MDS-UPDRS and UPDRS [26, 27].
These findings could be a starting point for exploration of
possible subscales within the MDS-UPDRS.
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